Report cover image

Global Biologic Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Jul 16, 2025
Length 191 Pages
SKU # APRC20278607

Description

Summary

According to APO Research, The global Biologic Drugs market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Biologic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Biologic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Biologic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Biologic Drugs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Biologic Drugs include Abbott Laboratories, Amgen, Amgen, Pfizer, Eli Lilly, Roche, Merck & Co., Novartis and Johnson & Johnson, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Biologic Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Biologic Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Biologic Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Biologic Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Biologic Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Biologic Drugs sales, projected growth trends, production technology, application and end-user industry.

Biologic Drugs Segment by Company

Abbott Laboratories
Amgen
Amgen
Pfizer
Eli Lilly
Roche
Merck & Co.
Novartis
Johnson & Johnson
Sanofi
Biologic Drugs Segment by Type

Humira
Avastin
Enbrel
Herceptin
Lantus
Remicade
Rituxan
Others
Biologic Drugs Segment by Application

Auto-Immune Diseases
Inflammation
Blood Diseases
Cardiovascular Diseases
Diabetes
Others
Biologic Drugs Segment by Region

North America

United States
Canada
Europe

Germany
France
U.K.
Italy
Netherlands
Asia-Pacific

China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America

Mexico
Brazil
Argentina
Middle East & Africa

Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biologic Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biologic Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biologic Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Biologic Drugs market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Biologic Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Biologic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Biologic Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

191 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Biologic Drugs Market Size, 2020 VS 2024 VS 2031
1.3 Global Biologic Drugs Market Size Estimates and Forecasts (2020-2031)
1.4 Global Biologic Drugs Sales Estimates and Forecasts (2020-2031)
1.5 Global Biologic Drugs Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Biologic Drugs Market Dynamics
2.1 Biologic Drugs Industry Trends
2.2 Biologic Drugs Industry Drivers
2.3 Biologic Drugs Industry Opportunities and Challenges
2.4 Biologic Drugs Industry Restraints
3 Biologic Drugs Market by Manufacturers
3.1 Global Biologic Drugs Revenue by Manufacturers (2020-2025)
3.2 Global Biologic Drugs Sales by Manufacturers (2020-2025)
3.3 Global Biologic Drugs Average Sales Price by Manufacturers (2020-2025)
3.4 Global Biologic Drugs Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Biologic Drugs Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Biologic Drugs Manufacturers, Product Type & Application
3.7 Global Biologic Drugs Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Biologic Drugs Market CR5 and HHI
3.8.2 Global Top 5 and 10 Biologic Drugs Players Market Share by Revenue in 2024
3.8.3 2024 Biologic Drugs Tier 1, Tier 2, and Tier 3
4 Biologic Drugs Market by Type
4.1 Biologic Drugs Type Introduction
4.1.1 Humira
4.1.2 Avastin
4.1.3 Enbrel
4.1.4 Herceptin
4.1.5 Lantus
4.1.6 Remicade
4.1.7 Rituxan
4.1.8 Others
4.2 Global Biologic Drugs Sales by Type
4.2.1 Global Biologic Drugs Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Biologic Drugs Sales by Type (2020-2031)
4.2.3 Global Biologic Drugs Sales Market Share by Type (2020-2031)
4.3 Global Biologic Drugs Revenue by Type
4.3.1 Global Biologic Drugs Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Biologic Drugs Revenue by Type (2020-2031)
4.3.3 Global Biologic Drugs Revenue Market Share by Type (2020-2031)
5 Biologic Drugs Market by Application
5.1 Biologic Drugs Application Introduction
5.1.1 Auto-Immune Diseases
5.1.2 Inflammation
5.1.3 Blood Diseases
5.1.4 Cardiovascular Diseases
5.1.5 Diabetes
5.1.6 Others
5.2 Global Biologic Drugs Sales by Application
5.2.1 Global Biologic Drugs Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Biologic Drugs Sales by Application (2020-2031)
5.2.3 Global Biologic Drugs Sales Market Share by Application (2020-2031)
5.3 Global Biologic Drugs Revenue by Application
5.3.1 Global Biologic Drugs Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Biologic Drugs Revenue by Application (2020-2031)
5.3.3 Global Biologic Drugs Revenue Market Share by Application (2020-2031)
6 Global Biologic Drugs Sales by Region
6.1 Global Biologic Drugs Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Biologic Drugs Sales by Region (2020-2031)
6.2.1 Global Biologic Drugs Sales by Region (2020-2025)
6.2.2 Global Biologic Drugs Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Biologic Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Biologic Drugs Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Biologic Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Biologic Drugs Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Biologic Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Biologic Drugs Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Biologic Drugs Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Biologic Drugs Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Biologic Drugs Revenue by Region
7.1 Global Biologic Drugs Revenue by Region
7.1.1 Global Biologic Drugs Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Biologic Drugs Revenue by Region (2020-2025)
7.1.3 Global Biologic Drugs Revenue by Region (2026-2031)
7.1.4 Global Biologic Drugs Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Biologic Drugs Revenue (2020-2031)
7.2.2 North America Biologic Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Biologic Drugs Revenue (2020-2031)
7.3.2 Europe Biologic Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Biologic Drugs Revenue (2020-2031)
7.4.2 Asia-Pacific Biologic Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Biologic Drugs Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Biologic Drugs Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Abbott Laboratories
8.1.1 Abbott Laboratories Comapny Information
8.1.2 Abbott Laboratories Business Overview
8.1.3 Abbott Laboratories Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Abbott Laboratories Biologic Drugs Product Portfolio
8.1.5 Abbott Laboratories Recent Developments
8.2 Amgen
8.2.1 Amgen Comapny Information
8.2.2 Amgen Business Overview
8.2.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Amgen Biologic Drugs Product Portfolio
8.2.5 Amgen Recent Developments
8.3 Amgen
8.3.1 Amgen Comapny Information
8.3.2 Amgen Business Overview
8.3.3 Amgen Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Amgen Biologic Drugs Product Portfolio
8.3.5 Amgen Recent Developments
8.4 Pfizer
8.4.1 Pfizer Comapny Information
8.4.2 Pfizer Business Overview
8.4.3 Pfizer Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Pfizer Biologic Drugs Product Portfolio
8.4.5 Pfizer Recent Developments
8.5 Eli Lilly
8.5.1 Eli Lilly Comapny Information
8.5.2 Eli Lilly Business Overview
8.5.3 Eli Lilly Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Eli Lilly Biologic Drugs Product Portfolio
8.5.5 Eli Lilly Recent Developments
8.6 Roche
8.6.1 Roche Comapny Information
8.6.2 Roche Business Overview
8.6.3 Roche Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Roche Biologic Drugs Product Portfolio
8.6.5 Roche Recent Developments
8.7 Merck & Co.
8.7.1 Merck & Co. Comapny Information
8.7.2 Merck & Co. Business Overview
8.7.3 Merck & Co. Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Merck & Co. Biologic Drugs Product Portfolio
8.7.5 Merck & Co. Recent Developments
8.8 Novartis
8.8.1 Novartis Comapny Information
8.8.2 Novartis Business Overview
8.8.3 Novartis Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Novartis Biologic Drugs Product Portfolio
8.8.5 Novartis Recent Developments
8.9 Johnson & Johnson
8.9.1 Johnson & Johnson Comapny Information
8.9.2 Johnson & Johnson Business Overview
8.9.3 Johnson & Johnson Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Johnson & Johnson Biologic Drugs Product Portfolio
8.9.5 Johnson & Johnson Recent Developments
8.10 Sanofi
8.10.1 Sanofi Comapny Information
8.10.2 Sanofi Business Overview
8.10.3 Sanofi Biologic Drugs Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 Sanofi Biologic Drugs Product Portfolio
8.10.5 Sanofi Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Biologic Drugs Value Chain Analysis
9.1.1 Biologic Drugs Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Biologic Drugs Production Mode & Process
9.2 Biologic Drugs Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Biologic Drugs Distributors
9.2.3 Biologic Drugs Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.